Related references
Note: Only part of the references are listed.Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival
Ying-Chun Shen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
3,3′-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation
K. M. Wahidur Rahman et al.
CANCER RESEARCH (2009)
Survivin: A new target for anti-cancer therapy
Brid M. Ryan et al.
CANCER TREATMENT REVIEWS (2009)
A phase I study of an antisense oligonucleotide against survivin (LY2181308) in Japanese patients with solid tumors
Hiroshi Nokihara et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells
Hui Xing et al.
CANCER LETTERS (2008)
Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models
Franz Roedel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells
Cindy G. Leung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
Katsutoshi Tokushige et al.
JOURNAL OF HEPATOLOGY (2007)
Predicting drug response and toxicity based on gene polymorphisms
J Robert et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma
SM Ansell et al.
LEUKEMIA (2004)
Toxicology of antisense therapeutics
TLH Jason et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2 '-O-(2-methoxyethyl) modified antisense oligonucleotide: Comparison across species
RS Geary et al.
DRUG METABOLISM AND DISPOSITION (2003)
Targeting Survivin Expression Induces Cell Proliferation Defect and Subsequent Cell Death Involving Mitochondrial Pathway in Myeloid Leukemic Cell
Bing Z. Carter et al.
CELL CYCLE (2003)
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
N Zaffaroni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
